Personalized Psychiatry Market, By Type (Products, Services, Software), By Therapeutic Areas (Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction, Others), By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
Personalized Psychiatry Market, By Type (Products, Services, Software), By Therapeutic Areas (Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction, Others), By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
Personalized psychiatry is an emerging field within the realm of mental healthcare that aims to revolutionize the way mental illnesses are diagnosed and treated. Traditionally, psychiatry has relied on a one-size-fits-all approach, where patients are prescribed medications or therapies based on broad diagnostic criteria. Using individual patient-specific genetic, biological, and clinical data, personalized psychiatry creates specialized mental health treatments and therapies. It seeks to replace the one-size-fits-all strategy with a more focused, customized one. Among the important technologies utilized are wearable biosensors, computerized therapy programs, quantitative EEG, pharmacogenomic testing, and molecular diagnostics. Growing public awareness of mental health issues, developments in neurobiology and genomics, and the need for better mental health diagnosis and treatment outcomes are the primary factors propelling the market.
Market Dynamics:
The personalized psychiatry market is expected to witness significant growth in the coming years, driven by several key factors such as rapid advancement of digital health technologies, innovations in genomics, wearables, and mobile apps. In addition, artificial intelligence in the field of mental health assessment and treatment is also expected to drive market growth over the forecast period. These technologies enable the collection of real-time data, allowing clinicians to monitor patients remotely and make informed decisions about their care.
However, the personalized psychiatry market also faces some challenges. One of the main restraints is the high cost associated with implementing personalized approaches. Developing and deploying advanced technologies can be expensive, and there may be limited reimbursement options for these services. Furthermore, there are regulatory and ethical considerations surrounding the use of genetic and digital data in mental healthcare, which may slow down the adoption of personalized approaches.
Key features of the study:
This report provides in-depth analysis of the global personalized psychiatry market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global personalized psychiatry market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include GreyBird Ventures, Sunovion Pharmaceuticals Inc., HMNC Holding GmbH, Arcara Personalized Psychiatry, Starling Minds, Karuna Therapeutics, CBT Plus, AltheaDx, Inc., WayForward, BrightQuest, Peak Mental Wellness
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global personalized psychiatry market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global personalized psychiatry market
Detailed Segmentation:
By Type:
Products
Diagnostics
Therapeutics
Services
Software
By Therapeutic Areas:
Depression
Anxiety
Bipolar Disorder
Schizophrenia
Addiction
Others
By Region
North America
Latin America
Europe
Asia Pacific
Middle East
Africa
Top companies in Personalized Psychiatry Market:
GreyBird Ventures
Sunovion Pharmaceuticals Inc.
HMNC Holding GmbH
Arcara Personalized Psychiatry
Starling Minds
Karuna Therapeutics
CBT Plus
AltheaDx, Inc.
WayForward
BrightQuest
Peak Mental Wellness
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Personalized Psychiatry, By Type
Market Personalized Psychiatry, By Therapeutic Areas
Market Personalized Psychiatry, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Growing need for improved diagnosis and treatment outcomes in mental healthcare
Rising prevalence of mental disorders
Growing adoption of precision medicine model in healthcare
Restraints
Opportunities
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER’s Analysis
Merger and Acquisition Scenario
4. Personalized Psychiatry Market – Impact of Coronavirus (COVID-19) Pandemic
COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact
5. Personalized Psychiatry Market , By Type, 2018-2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2019 – 2030
Segment Trends
Products
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Diagnostics
Therapeutics
Services
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Software
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)